J&J to pump another $13B into its MedTech business with Shockwave deal
Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
The health care giant said Friday that it will spend $335 in cash for each share of Shockwave. The total deal value includes cash acquired.
The deal has already been approved by the boards of directors from both companies.
Founded in 2009, Shockwave focuses on intravascular lithotripsy technology that uses sonic pressure waves to crack calcium lesions in arteries and restore blood flow. It’s similar to a technique used to break up kidney stones. The soundwave emitters are placed inside angioplasty catheters to reach the calcified areas of the artery.
Shockwave’s technology is used to treat coronary artery and peripheral artery disease.
The company’s revenue jumped 49% last year to $730 million.
Related articles
Goldman Sachs upbeat on A shares
Goldman Sachs, a global investment banking, securities and investment management firm, sees double-d2024-04-30John Sterling honored by Yankees for 36 seasons and 5,631 games as radio voice
NEW YORK (AP) — After 36 seasons as the voice of the New York Yankees, John Sterling needed just 902024-04-30Jordan Montgomery wins in debut, Diamondbacks get 22 hits in 17
SAN FRANCISCO (AP) — Jordan Montgomery pitched six strong innings in his season debut, Blaze Alexand2024-04-30Live video of man setting himself on fire outside court challenges news organizations
NEW YORK (AP) — Video cameras stationed outside the Manhattan courthouse where former President Dona2024-04-30Insider Q&A: Avelo Airlines CEO Andrew Levy describes the challenges of starting a new carrier
It’s not easy to break into the U.S. airline industry, which is dominated by four big carriers and a2024-04-30Milwaukee teenager gets 13 years for shooting inside restaurant that killed 2 other teens
MILWAUKEE (AP) — A Milwaukee teenager has been sentenced to 13 years in prison after pleading guilty2024-04-30
atest comment